To evaluate the effectiveness of targeted therapy on preventing or treating COVID-19, in this study, we want to share our experience about 14 patients (nine women, five men; average age, 59 years) who were treated with targeted therapy due to their underlying malignant disorders in our center.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576967 | PMC |
http://dx.doi.org/10.1002/ccr3.6392 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!